CD44 and breast carcinoma: The heterogeneous nuclear ribonucleoprotein M (hnRNPM) promotes epithelial-mesenchymal transition (EMT) and metastasis in breast cancer by promoting the biased expression of CD44 standard isoform (CD44s) [7].